Hypothesis

Chronic JNK2 activity, but not JNK1, selectively phosphorylates JunD at serine‑73 (S73), promoting its dissociation from cJun and enabling Fra‑1 recruitment to form cJun‑Fra‑1 heterodimers that preferentially bind SASP enhancers. This phospho‑switch converts AP-1 from a proliferative to an inflammatory chromatin state, locking cells into the senescence-associated secretory phenotype (SASP).

Mechanistic Rationale

1. Isoform‑specific substrate preference – Structural modeling shows JNK2’s docking groove accommodates JunD’s S73 motif with higher affinity than JNK1, predicting preferential phosphorylation.
2. Phospho‑dependent dimer remodeling – Phospho‑S73 creates a docking site for the E3 ligase FBXW7, which ubiquitinates JunD, reducing its stability and freeing cJun to pair with Fra‑1, whose expression is ROS‑induced.
3. Chromatin outcome – cJun‑Fra‑1 dimers recruit the SWI/SNF subunit BRG1 to NF‑κB‑cooccupied SASP promoters, increasing nucleosome accessibility and sustaining transcription, whereas unmodified JunD‑cJun dimers favor binding to cell‑cycle promoters (e.g., cyclin D1) and recruit HDAC1.
4. Feedback loop – SASP‑derived IL‑6 amplifies mitochondrial ROS via STAT3‑dependent NOX4 activation, maintaining JNK2 activity and thus the phospho‑switch, creating a self‑reinforcing inflammaging circuit.

Testable Predictions

• Phospho‑specific detection – JunD‑pS73 levels will be low in young proliferating fibroblasts, rise sharply after >48 h of H₂O₂‑induced mitochondrial stress, and correlate with SASP onset.
• Isoform knockout/rescue – JNK2‑KO cells will retain JunD‑cJun dimers and fail to up‑regulate SASP despite chronic ROS, whereas JNK1‑KO will show normal SASP induction.
• Mutagenesis – Expressing a JunD‑S73A mutant will block the JunD→Fra‑1 switch, reduce BRG1 recruitment at IL6 and IL8 promoters, and attenuate SASP without affecting acute stress‑induced cJun phosphorylation.
• Pharmacological inhibition – A JNK2‑selective inhibitor (e.g., CC‑930) administered after the acute phase will diminish JunD‑pS73, preserve JunD‑cJun binding to proliferative genes, and lower SASP cytokine secretion in aged mouse tissues.
• Chromatin profiling – Time‑resolved ChIP‑seq for JunD, cJun, Fra‑1, and BRG1 in senescence models will show a temporal shift from JunD/cJun occupancy at CCND1 to cJun/Fra‑1/BRG1 occupancy at SASP loci coincident with JunD‑pS73 accumulation.

Falsifiability

If JunD‑pS73 is undetectable during chronic JNK activation, or if JunD‑S73A expression does not alter AP‑1 dimer composition or SASP output, the hypothesis is refuted. Likewise, if JNK1 deficiency abolishes SASP while JNK2 deficiency does not, the isoform specificity claim fails.

Broader Impact

Delineating a JNK2‑JunD‑S73 phospho‑switch provides a molecular timer that distinguishes transient protective JNK signaling from chronic pathogenic signaling, offering a target for interventions that inhibit the maladaptive AP‑1 remodel without compromising acute stress responses.

References

[1] https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2024.1453710/full [2] https://doi.org/10.1101/gad.331272.119 [3] https://www.pnas.org/doi/10.1073/pnas.0707782104 [4] https://pmc.ncbi.nlm.nih.gov/articles/PMC7226813/ [5] https://doi.org/10.1038/ncomms14995 [6] https://doi.org/10.1101/gr.240093.118 [7] https://pmc.ncbi.nlm.nih.gov/articles/PMC2801623/